Company Filing History:
1 out of 3,701 
1 out of 2,320 
2 out of 833,002 Years Active: 1999-2003
Title: The Innovative Contributions of Karen Hsiao
Introduction
Karen Hsiao is a prominent inventor based in North Oaks, MN (US). She has made significant contributions to the field of biomedical research, particularly in the study of Alzheimer's disease. With a total of 3 patents to her name, her work has advanced our understanding of neurodegenerative disorders.
Latest Patents
One of her latest patents involves the development of transgenic mice expressing mutant human amyloid precursor protein (APP) and forming Congo red staining plaques. This invention provides a transgenic non-human eukaryotic animal whose germ cells and somatic cells contain the APP sequence introduced at an embryonic stage. In these mice, an age-related central nervous system disorder develops, characterized by agitation, neophobia, seizures, inactivity, diminished cerebral glucose utilization, cortico-limbic gliosis, and ultimately death. The disorder accelerates in transgenic mice expressing both human and mouse APP, produced using a hamster prion protein gene-derived cosmid vector. This vector confers position-independent, copy number-dependent expression. The disorder develops in direct relation to brain levels of transgenic APP, with mutant APP conferring the phenotype at lower levels of expression than wild-type APP. Notably, the disorder occurs in the absence of extracellular amyloid deposition, indicating that some pathogenic activities of APP are dissociated from amyloid formation.
Another significant patent by Hsiao involves transgenic mice expressing APP mutants at amino acids 717, 721, and 722. This invention also introduces the APP sequence into the germ cells and somatic cells of a non-human eukaryotic animal at an embryonic stage.
Career Highlights
Throughout her career, Karen Hsiao has worked with esteemed institutions, including The Johns Hopkins University. Her research has been pivotal in understanding the mechanisms underlying Alzheimer's disease and related disorders.
Collaborations
Karen has collaborated with notable researchers such as David R. Borchelt and Sangram S. Sisodia. Their combined efforts have contributed to significant advancements in the field of neurobiology.
Conclusion
Karen Hsiao's innovative work and patents have made a lasting impact on the understanding of Alzheimer's disease and its mechanisms. Her contributions continue to inspire future research in the field of neurodegenerative disorders.